Smartphone-based– tag –
-
Software-Driven Method Improves Detection Limits in Capillary Diagnostic Assays, Reliably Identifying Weak Positive Samples Earlier
Preprints.org International Overview This study proposes a software-driven method utilizing kinetic image analysis and time-resolved signal extraction to improve the detection limits of capillary diagnostic assays (e.g., lateral flow imm... -
ProPharma FAQ: POCT & Diagnostic Miniaturization Reshape IVD Future, Driven by Wearables & AI
ProPharma USA Overview Point-of-care testing (POCT) and diagnostic miniaturization are rapidly reshaping the future of in vitro diagnostics (IVDs). Miniaturized instrument hardware, improved sensor technology, and portable diagnostic too... -
ACS Applied Nano Materials Reviews Single-Atom Nanozymes: Drastically Improving Sensitivity and Specificity for Biomolecule and Pollutant Detection
ACS Applied Nano Materials USA Overview Single-atom nanozymes (SAzymes) significantly reduce detection limits (LOD) and improve detection sensitivity and specificity due to their highly efficient substrate catalysis. These properties pos... -
Smartwatches Revolutionize Blood Sugar Management: Dexcom G7 and FreeStyle Libre Enhance Apple Watch Integration, Expanding AI-Driven Ecosystem
TechRepublic USA Overview Smartwatches hold the potential to transform glucose tracking, but current advancements rely on the integration of continuous glucose monitoring (CGM), artificial intelligence (AI), and regulated healthcare tech... -
The Rise of Finger-Prick-Free Glucose Monitoring: Dexcom Stelo, Abbott Lingo, and the CGM Revolution in Metabolic Health
Mattioli 1885 イタリア Overview The U.S. FDA has approved a new generation of finger-prick-free continuous glucose monitors (CGMs) that measure interstitial fluid glucose and transmit real-time data to smartphones, largely eliminating da... -
FDA Clears Dexcom Stelo as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children (Ages 2+)
HCPLive USA Overview The FDA has approved Dexcom's Stelo Glucose Biosensor System for over-the-counter (OTC) use in children aged 2 years and older who do not use insulin. This marks Stelo as the first OTC continuous glucose monitoring (... -
UTMB Researchers Secure USDA Funding for AI-Enabled Nanobody Biosensor for Rapid Screwworm Detection, Achieving 15-Minute Field Results
The University of Texas Medical Branch USA Overview Researchers at the University of Texas Medical Branch (UTMB) have received USDA funding to develop an AI-enabled rapid detection system for screwworm, safeguarding Texas livestock and w... -
Precision and Provenance: Why Regulatory Approval and MARD Transparency Define the Future of Glucose Monitoring
Mattioli 1885 イタリア Overview A recent report on the 2026 glucose monitoring market highlights the transformative role of Continuous Glucose Monitoring (CGM) in diabetes management. It underscores that robust quality indicators—specifi... -
Abbott’s FreeStyle Libre Offers 10-Day Real-Time Glucose Monitoring for Diabetes Patients Aged 4 and Up
Health Insider Canada Overview Abbott Laboratories' FreeStyle Libre system provides continuous glucose monitoring for diabetes patients aged four and older, utilizing a small wearable sensor and a smartphone app. This system delivers rea... -
i-SENS’s CareSens Air CGM Secures Belgian Reimbursement, Paving the Way for Expanded European Market Penetration
i-SENS (アジア経済新聞経由) South Korea, ベルギー Overview South Korean medical device firm i-SENS has achieved a critical milestone with its "CareSens Air" continuous glucose monitoring (CGM) device, securing public insurance reimbursem...
